Pillar Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,155
Closed -$204K 72
2023
Q3
$204K Hold
6,155
0.18% 67
2023
Q2
$226K Sell
6,155
-1,024
-14% -$39.9K 0.19% 63
2023
Q1
$293K Buy
7,179
+824
+13% +$35.6K 0.29% 54
2022
Q4
$326K Hold
6,355
0.31% 50
2022
Q3
$278K Hold
6,355
0.28% 46
2022
Q2
$333K Hold
6,355
0.34% 42
2022
Q1
$329K Sell
6,355
-5,172
-45% -$268K 0.32% 41
2021
Q4
$681K Buy
+11,527
New +$571K 0.65% 29

Other funds holding PFE

Pillar Wealth Advisors's PFE Position: Q4 2023 in Review

Pillar Wealth Advisors sold out of Pfizer (PFE) in Q4 2023, closing a stake of 6,155 shares — an estimated $204K sold.

Pillar Wealth Advisors first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $681K in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Pillar Wealth Advisors reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Pillar Wealth Advisors sold 6,155 Pfizer shares in Q4 2023, an estimated $204K.
  • Pillar Wealth Advisors first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
  • Pillar Wealth Advisors's Pfizer position peaked at $681K in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Pillar Wealth Advisors's 13F filing for Q4 2023, filed 5 Feb 2024.